Engineered T-Cell Therapy for Patients With ALPP-Positive Advanced Solid Tumors

Clinical trial NCT07123493 · TERMINATED

Trial details

NCT number: NCT07123493
Sponsor: Haifeng Qin
Status: TERMINATED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Recurrent or Metastatic Solid Tumors With Positive ALPP

Start date: 2025-08-28
Primary completion: 2025-12-30
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.